文献速递重症综合管理与镇静镇痛复苏、休克与脓毒症

脓毒症后慢性危重症患者的临床特征分析

[Analysis of clinical characteristics of patients with chronic critical illness after sepsis].
PubMed 文献 · Zhonghua Wei Zhong Bing Ji Jiu Yi Xue · 2021-01-01
一句话结论脓毒症后发生慢性危重症者年龄更大、APACHE II与SOFA评分更高、合并脓毒性休克比例更高,180天累积生存率显著低于快速恢复组(63.6% vs 96.4%,P=0.007)。

该研究纳入2019年4月至2020年10月深圳市宝安区中心医院重症医学科首次收治的脓毒症存活患者,按临床结局分为慢性危重症(CCI)组(ICU停留≥14天且持续器官功能障碍)与快速恢复(RAP)组,比较入院基线特征与临床结局,并检测入住ICU第1、7、14天血清IL-6、IL-10水平及外周血淋巴细胞计数。CCI组22例、RAP组28例;CCI组年龄、APACHE II评分、SOFA评分、脓毒性休克比例、机械通气时间、ICU停留时间、总住院时间及继发感染比例均高于RAP组(均P<0.05)。CCI组IL-6在第1、7、14天均高于RAP组,第14天IL-10更高而淋巴细胞计数更低。Kaplan-Meier生存曲线Log-Rank检验显示CCI组180天累积生存率显著低于RAP组。

要点

  • 脓毒症存活者中CCI组22例、RAP组28例,CCI组年龄61.0±13.8岁 vs RAP组50.3±13.9岁,≥65岁比例54.5%(12/22)vs 25.0%(7/28),均P<0.05。
  • CCI组APACHE II评分20.5±4.4 vs 14.4±4.3、SOFA评分10(7,12)vs 5(3,8)、脓毒性休克比例40.9%(9/22)vs 17.9%(5/28),均P<0.05。
  • CCI组机械通气时间18.5(12.0,28.0)天 vs 5.0(3.0,7.0)天、ICU停留26(18,46)天 vs 8(6,12)天、总住院31(26,51)天 vs 14(12,17)天,均P<0.05。
  • CCI组继发感染比例72.7%(16/22)vs RAP组7.1%(2/28),P<0.05;180天累积生存率63.6% vs 96.4%(Log-Rank χ2=9.024,P=0.007)。
  • CCI组IL-6在第1、7、14天均高于RAP组(均P<0.05);第14天IL-10为15.09±3.61 ng/L vs 8.92±1.98 ng/L、淋巴细胞计数0.62(0.43,1.02)×10^9/L vs 1.17(0.93,1.71)×10^9/L,均P<0.05。

适用人群与场景

  • 2019年4月至2020年10月深圳市宝安区中心医院重症医学科首次收治的脓毒症存活患者。
  • 按临床结局分为CCI组(ICU停留≥14天且持续器官功能障碍)与快速恢复(RAP)组。

诊断标准与关键阈值

  • CCI判定标准:ICU停留≥14天,且存在持续器官功能障碍。

研究设计与关键结果

  • 研究类型为临床特征分析,纳入脓毒症存活患者50例,其中CCI组22例、RAP组28例。
  • 两组性别与感染部位无显著差异;CCI组年龄(61.0±13.8岁 vs 50.3±13.9岁)、≥65岁比例(54.5%(12/22)vs 25.0%(7/28))、APACHE II评分(20.5±4.4 vs 14.4±4.3)、SOFA评分(10(7,12)vs 5(3,8))、脓毒性休克比例(40.9%(9/22)vs 17.9%(5/28))、机械通气时间(18.5(12.0,28.0)天 vs 5.0(3.0,7.0)天)、ICU停留时间(26(18,46)天 vs 8(6,12)天)、总住院时间(31(26,51)天 vs 14(12,17)天)及继发感染比例(72.7%(16/22)vs 7.1%(2/28))均高于RAP组,均P<0.05。
  • CCI组IL-6在第1天(176.86±103.54 ng/L vs 113.32±71.34 ng/L)、第7天(84.72±46.06 ng/L vs 54.98±26.61 ng/L)、第14天(44.28±20.20 ng/L vs 17.76±4.70 ng/L)均高于RAP组,均P<0.05。
  • 第1天和第7天两组IL-10与淋巴细胞计数无显著差异;第14天CCI组IL-10高于RAP组(15.09±3.61 ng/L vs 8.92±1.98 ng/L,P<0.05),淋巴细胞计数低于RAP组(0.62(0.43,1.02)×10^9/L vs 1.17(0.93,1.71)×10^9/L,P<0.05)。
  • Kaplan-Meier生存曲线Log-Rank检验显示,CCI组180天累积生存率显著低于RAP组(63.6% vs 96.4%,χ2=9.024,P=0.007)。

证据类型、等级与局限

  • 证据类型:临床特征分析(观察性研究)。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,高龄、高APACHE II评分和高SOFA评分的脓毒症患者易继发CCI,导致住院时间长、继发感染率高和预后差。
  • 作者认为,CCI的发生可能与促炎介质持续表达及随后的免疫抑制有关。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

OBJECTIVE: To investigate the clinical characteristics of patients who develop chronic critical illness (CCI) after sepsis.

METHODS: The survival patients with sepsis admitted to the department of critical medicine of Baoan Central Hospital of Shenzhen for the first time from April 2019 to October 2020 were enrolled. According to clinical outcomes, patients were divided into CCI group [intensive care unit (ICU) stay ≥ 14 days, with persistent organ dysfunction] and rapid recovery (RAP) group. The baseline characteristic on admission and clinical outcomes of patients in the two groups were collected and compared. Blood samples were collected to measure serum interleukins (IL-6, IL-10) levels and peripheral blood lymphocyte count (LYM) count were obtained from all patients after admission. The differences of above indexes on the 1st, 7th and 14th day in ICU between the two groups were compared, the 180 day cumulative survival rate of the two groups was observed.

RESULTS: (1) Twenty-two septic patients developed CCI and 28 patients with RAP were included. There were no significant differences in gender and infection site between the two groups. The age, acute physiology and chronic health evaluation II (APACHE II), sequential organ failure assessment (SOFA), proportion of septic shock, mechanical ventilation time, length of ICU stay, total length of hospital stay and proportion of secondary infection of CCI patients were higher than those in RAP group [age (years old): 61.0±13.8 vs. 50.3±13.9, proportion of patients aged ≥ 65 years old: 54.5% (12/22) vs. 25.0% (7/28), APACHE II score: 20.5±4.4 vs. 14.4±4.3, SOFA score: 10 (7, 12) vs. 5 (3, 8), septic shock ratio: 40.9% (9/22) vs. 17.9% (5/28), time of mechanical ventilation (days): 18.5 (12.0, 28.0) vs. 5.0 (3.0, 7.0), length of ICU stay (days): 26 (18, 46) vs. 8 (6, 12), total length of hospital stay (days): 31 (26, 51) vs. 14 (12, 17), secondary infection ratio: 72.7% (16/22) vs. 7.1% (2/28), all P < 0.05]. (2) The IL-6 levels of CCI group were higher than that of RAP group at all time points (ng/L: 176.86±103.54 vs. 113.32±71.34 on the 1st day, 84.72±46.06 vs. 54.98±26.61 on the 7th day, 44.28±20.20 vs. 17.76±4.70 on the 14th day, all P < 0.05). On the 1st and 7th day of admission, there were no significant differences in IL-10 and LYM levels between the two groups. On the 14th day of admission, IL-10 levels in CCI group were higher than that in RAP group (ng/L: 15.09±3.61 vs. 8.92±1.98, P < 0.05), while LYM was relatively lower [×109/L: 0.62 (0.43, 1.02) vs. 1.17 (0.93, 1.71), P < 0.05]. (3) The Log-Rank test results of Kaplan-Meier survival curve showed that the 180-day cumulative survival rate of CCI group was significantly lower than that of RAP group (63.6% vs. 96.4%, Log-Rank: χ2 = 9.024, P = 0.007).

CONCLUSIONS: Septic patients with advanced age, high APAHCE II score and high SOFA score are prone to secondary CCI, resulting in long hospital stay, high secondary infection rate and poor prognosis. The occurrence of CCI may be related to the continuous expression of proinflammatory mediators and subsequent immunosuppression.

来源:Zhonghua Wei Zhong Bing Ji Jiu Yi Xue,查看原文。版权归原作者所有。

参考来源

  1. Chen L, Cao R, Wang J, et al. [Analysis of clinical characteristics of patients with chronic critical illness after sepsis]. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2021. PMID: 35131005. doi:10.3760/cma.j.cn121430-20210706-01014

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。